Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Impact Biomedical Inc.

NYSE: IBO · Life Sciences · 5 alerts · CIK 1834105

Share price
$4.91Close, Nov 16
Market cap
$42.4M
Shares outstanding
8.64MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Impact Biomedical Inc. filings on SEC EDGAR ↗

4:51 PM ET 10-Q
Financial Results

Impact Biomedical Q3 2026 Results: Net Loss of $645K, Loss Narrows

Impact BioMedical reported a net loss of $3.63 million for the nine months ended September 30, 2026, a significant improvement from the $17.11 million loss in the prior year period which was driven by a $13.21 million change in fair value of a related party note. The company maintains a minimal revenue base of $31,000 and continues to focus on developing its proprietary healthcare technologies like Linebacker™.

Key figure
Net loss $645K

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.